INTRODUCTION
Background and Rationale. The patient-centered medical home (PCMH) model has been widely promoted for its potential to improve the quality and value of care, as well as patient experience.
1,2 PCMH evaluations focus on both the general population and high-risk subpopulations with medical comorbidities, who may disproportionally benefit from PCMH components such as care coordination. 3, 4 Evidence reviews suggest that the hypothesized gains have yet to be fully realized. 5, 6 Some investigators have found better experiences for patients in at least some measures in PCMH practices, [7] [8] [9] [10] [11] [12] while others report little or no difference from traditional practices, [13] [14] [15] [16] [17] [18] leading some to doubt the potential for PCMH transformation as a means of achieving reliable improvements in experience of care. 18 One possible explanation for the inconclusive findings is that they may reflect evaluations of partial PCMH implementation or evaluations taking place during the initial phases of PCMH transformation, when change can be hard on both providers and patients. 14, 15 Increasingly, the Centers for Medicare and Medicaid Services (CMS) and other payers are coming together in multipayer initiatives based on the idea that alignment across payers will provide more resources and sharpen provider focus to accelerate change. 19, 20 The effects of these demonstrations on patient experience have yet to appear in the peer-reviewed Electronic supplementary material The online version of this article (doi:10.1007/s11606-017-4139-2) contains supplementary material, which is available to authorized users.
literature, but some publicly available results still present a mixed picture. [21] [22] [23] The Michigan Primary Care Transformation (MiPCT) is possibly the largest multi-payer PCMH initiative in the country, with five participating payers (Medicare, Medicaid, and three commercial payers) and over 1.2 million patients (12% of the state's population). Thus MiPCT is an excellent context in which to study the relationship between a well-supported and mature PCMH program and patient experience.
Objectives. The current study contributes to the literature by comparing the care experience of patients in a multi-payer PCMH demonstration relative to patients not served by PCMH. Moreover the study is designed with a second comparison group-patients served by newer PCMH practices that are not part of the demonstration, and therefore have fewer resources for transformation. We expect the greatest difference in experience to be between patients cared for by the mature, well-resourced practices in the MiPCT demonstration and the non-PCMH practices. We expect patients served by nonparticipating PCMHs to rate their experiences somewhere in between these two groups.
METHODS
Study Design. This study is a cross-sectional comparison employing a multi-mode survey of patient experience. Comparison practices were selected in 2012 as part of the overall MiPCT evaluation design. From MiPCT and comparison practices, stratified random sampling was utilized to select patients with oversampling based on high medical risk. The project was reviewed according to the protocols of the Michigan Public Health Institute (MPHI) Institutional Review Board and determined to be non-human subject research.
MiPCT PCMH Settings. MiPCT began with a planning year in 2011, and became operational in January 2012. The demonstration, originally designed for 3 years, was subsequently extended to continue through 2016. Practices eligible to participate in MiPCT all had PCMH designation in 2010 from the Blue Cross Blue Shield of Michigan (BCBSM) Physician Group Incentive Program (PGIP). 24, 25 This included 395 primary care practices and a participating provider base of 1900 physicians, physician assistants, and nurse practitioners. These practices represent a wide variety of settings (health system-owned, physician-owned and jointlyowned), sizes, and environments (rural, urban, suburban), including 11 Federally Qualified Health Centers (FQHCs).
The MiPCT payment model includes enhanced payment for practice transformation and embedded care management, and quality performance-based incentives. Practices were contractually obligated to 1) maintain either BCBSM or National Committee for Quality Assurance (NCQA) designation for the duration of the demonstration; 2) provide care management services using a ratio of two trained MiPCT Care Managers per 5000 patients; 3) maintain an all-patient registry to identify gaps in care and review performance dashboards; and 4) implement advanced access processes including 24/7 access to a clinical decision-maker, open-access scheduling, and options for care outside of business hours. MiPCT supplied practice transformation support for training and embedding Care Managers. Training topics addressed the MiPCT goals of 1) risk reduction for healthy individuals, 2) self-management support to prevent patients with moderate chronic disease levels from progressing to the complex category, 3) care coordination and support for patients with complex chronic diseases, 4) initiation of timely transition of care activities when patients experience emergency room or inpatient visits, and 5) coordinated end-of-life care.
Non-Participating PCMH Settings. Even as MiPCT supported enhanced transformation among participating PCMHs, private payers continued to recognize and reimburse new practices that achieved PCMH designation. Between 2010 and 2015, PCMH designations by BCBSM rose from 1647 to 4349 providers; NCQA designations rose from 185 in 2013 to 450 in 2015 (including both MiPCT and non-MiPCT PCMH providers). A key difference between non-MiPCT and MiPCT PCMHs (other than the enhanced resources and longer experience with designation as already described) is the lack of a payment model that specifically reimbursed for care management services. Because all MiPCT practices were designated by BCBSM (sometimes in addition to NCQA), comparison PCMH practices were limited to those with 2011 or 2012 BCBSM PCMH designation and not eligible for MiPCT (a total of 539 practices).
Non-PCMH Settings. A second comparison study setting of non-PCMH practices was selected using propensity score matching from all 1474 non-PCMH practices on the BCBSM PGIP list. Matching variables included observable practice characteristics that were available at the time, such as practice size, Medicaid and commercial patient volume, average patient risk scores, FQHC status, and urban/rural location (see online Appendix for methods and results of the matching procedure).
Participants. Survey respondents were selected from lists of patients attributed to practices in each study group. The sampling frame was further limited based on the following inclusion criteria: 1) a documented patient visit (in payer claims/encounter files) with their attributed/assigned primary care provider (PCP) during the year prior to the survey, and 2) age of 18 years or older as of survey implementation.
Sampling strata were defined by participating payer and study group. This led to 15 cells (three study groups and five payers), from which a random sample was selected, with the goal of achieving 250 completed surveys per cell. The actual sample size per cell was inflated based on known variation in response rates for each payer.
In addition, the study design called for an oversampling of high-risk patients with severe or chronic conditions. The number of the additional high-risk patients sampled for each stratum varied from payer to payer, as each payer had different proportions of high-risk patients. The supplemental high-risk samples, together with high-risk patients in the general population sample, made up the high-risk patient sample for additional analyses.
Surveys were fielded in January and February of 2015 by an NCQA-certified Consumer Assessment of Healthcare Providers and Systems (CAHPS) vendor. Two waves of mailings were completed, with postcard reminders sent to nonrespondents. Non-respondents were then called and given the option to complete the survey over the phone. Figure S1 in the online Appendix illustrates the flow of activities to construct the sample.
Variables and Measurement. The CAHPS surveys have become the gold standard for assessing patient experience in ambulatory care practices, [26] [27] [28] [29] [30] and are particularly well-suited for evaluating the impact of healthcare innovations. 31 The PCMH supplemental item set was released in late 2011, so not all prior research on patient experience and PCMH utilized CAHPS. Much of the published validation work has occurred within the last 5 years. 27, 29, 30 We fielded the survey at a time when NCQA was collecting information on proposed changes to the Clinician and Group (CG)-CAHPS 2.0 instrument and PCMH 2.0 item set. The study included items consistent with those recommended changes, not all of which were carried forward into the subsequent CG-CAHPS and PCMH 3.0 item set. This manuscript groups the items gathered to be consistent with the current CAHPS PCMH 3.0 domains (Table 1) including access to care, provider communication, care coordination, self-management support, comprehensiveness, and provider rating. We rescaled all items to a common 0-10 scale and computed composite scores for the first three domains following published methods for the employment of CAHPS measures in group comparisons, 32 described in more detail in the online Appendix. The sixth domain, the provider rating, was assessed by a single item.
Covariates included individual-level variables of education, race, insurance payer, and concurrent risk group. Covariates also included practice-level variables: practice size, hospital employment, and urban/rural location. Education and race were measured in the demographic section of the survey. Concurrent risk scores ranging from 0 to 99,999 were calculated from claims data using the Verisk Analytics DxCG RiskSmart software and served as proxy measures of morbidity and overall health status (Verisk Health/Verscend Technologies, Inc., Waltham, MA). Based on criteria provided by the analytics vendor, high-to very high-risk patients have scores 226 or above, indicating that they are heavy utilizers of the healthcare system, most often being treated for multiple high-severity acute conditions and/or chronic conditions. The concurrent risk score is based on both acute and chronic diagnoses grouped based on cost, as well as gender and age. Additional information about risk scores is included in the online Appendix. Table 1 The "Anyone" referent has been changed to "Somebody" in version 3.0
Practice size was defined as the number of primary care providers in the practice unit. For the geography variable, urban was defined in contrast to rural, in alignment with the Federal Office of Rural Health Policy as a practice census tract with Rural-Urban Commuting Area (RUCA) designations. Hospital employment is a binary practice-level covariate; 85% of providers are employed by a hospital.
Statistical Methods. We used the Complex Samples module in IBM SPSS version 23 software to conduct data processing and analysis. We first computed sampling weights that corrected for non-response and sample design. Then, via the CSPLAN procedure, we programmed the following: 1) data stratification, 3) data clustering at the practice level, and 3) sampling weights in the Complex Samples module. The resultant file was used in all subsequent analyses to account for the actual numbers of respondents within strata and for potential clustering effects when calculating standard errors. 33 The general linear model (CSGLM) procedure was employed for the four continuous outcome variables (access, coordination, communication, and provider rating), with post hoc comparisons to assess differences among MiPCT and comparison groups. Ordinal regression with the logit link function (CSORDINAL model) was used for the domains of self-management support and comprehensiveness (which can take only three values and therefore are not continuous). Both models controlled for potential confounding variables including race, education, payer group (Medicare, Medicaid, commercial insurance), health risk (very low, low, medium, high, very high), practice size, hospital ownership, and geography (urban, rural).
RESULTS
The final samples include 3893 patients from the general population served by 802 practices, and 4605 high-risk patients served by 829 practices (Tables 2 and 3 ). The overall response rate for the survey was 31.8% for the general population and 34.1% for the high-risk population. This response rate is typical for CAHPS mail surveys. 34 A total of 95 surveys, almost equally distributed across study groups, were completed by phone, representing 1.5% of all respondents. We examined non-response as a potential source of bias. Consistent with previous studies, non-response bias tests revealed that respondents were more likely to be female, older, on Medicare, and in the high-risk group. There were no significant differences in response rates among the MiPCT (32.9%), non-participating PCMH (32.3%), and non-PCMH (32.8%) patients.
Unadjusted demographic and clinical characteristics, including age, gender, race, level of education, risk group, urban/rural, and payer, are presented in Tables 2 and 3 . Within the general population, analyses (described in the online Appendix) revealed no significant between-group differences in demographic characteristics. Within the high-risk population, only education was a significant between-group patient demographic difference. However, in both the general and high-risk populations, there were pronounced significant study group differences for two of the practice characteristics, including practice size and employment. Figure 1a and b displays the weighted mean ratings by domain and study group for the general population and highrisk group, respectively. Table 4 (top) contains the adjusted mean difference between MiPCT and comparison-group patients for the domains of access, communication, coordination, and provider rating. Table 4 also presents the odds ratios for group comparisons in the domains of self-management support and comprehensiveness. MiPCT patients reported significantly better experiences in five of the six domains: access, communication with provider, coordination, self-management support, and comprehensiveness. Patients of non-participating PCMH practices reported significantly better experiences than non-PCMH patients in three domains: access, coordination, and comprehensiveness. Finally, MiPCT patients reported significantly better experiences than non-participating PCMH patients in two domains: comprehensiveness and self-management support.
Consistent with the general population results, analyses performed among high-risk patients revealed that MiPCT patients reported significantly better experiences than the non-PCMH group in the same five domains (Table 4 , bottom). In addition, group differences are marginally significant for the provider rating measure (p<0.06). Further, the nonparticipating PCMH patient group showed significantly higher scores than the non-PCMH group on four of the six domains, *Practice information is summarized at the patient level. The number of practices represented in each group of respondents is 290 (MiPCT), 380 (nonparticipating PCMH), and 159 (non-PCMH), for a total of 829 † Treated as a continuous variable in the mixed model analysis PCP primary care provider including access, coordination, self-management support, and comprehensiveness. For all four of these domains, MiPCT patients showed significantly higher adjusted mean scores than the non-participating PCMH patients. In terms of covariates, payer group was shown to have a significant association with access, communication, coordination, provider rating, and comprehensiveness (with Medicare patients reporting higher ratings and Medicaid patients reporting lower ratings across most domains, but commercial patients reporting better experiences in terms of comprehensiveness). A lower level of education (high school/some college) and Hispanic ethnicity was predictive of lower access among the general population. Smaller practice size was predictive of greater access. Detailed results are presented in the online Appendix.
DISCUSSION
The present study assessed the patient experience among practices in MiPCT-multi-payer PCMH initiative that Figure 1a and b. Global odds ratios are presented for ordinal variables implemented care management and other advanced practices supported by enhanced payment, training and mentorship, and ongoing learning opportunities-relative to both PCMH and non-PCMH practices that did not participate in the demonstration. First, the study confirms both of our initial hypotheses: that we would see the greatest differences in patient experience when we compared MiPCT patients and non-PCMH patients, and that we would see a differentiation between MiPCT and non-participating PCMH patients, and between those nonparticipating PCMH patients and non-PCMH patients. These findings confirm and extend previous reports of improved care experience associated with the PCMH model [7] [8] [9] [10] [11] [12] and may help to explain the equivocal results of previous PCMH evaluations of early or partial implementations. 14, 15 Our results are strengthened by the finding that much of the differentiation among study groups occurred in four domains of patient experience: access, coordination, self-management, and comprehensiveness. Practice capacities relevant to these domains are a major part of the intervention, and/or are specifically related to the PCMH model. For example, MiPCT practices were held to higher standards of access and hired Care Managers specifically charged with care coordination. In addition, self-management support and comprehensiveness are the only domains assessed that specifically came from the CAHPS PCMH item set (rather than the base CG-CAHPS tool).
The study also provides evidence to support the idea that multi-payer advanced PCMH implementation can confer benefits to patients in their experience of care over and above those of non-participating PCMHs. For self-management support and comprehensiveness, MiPCT PCMHs were rated higher than non-participating PCMHs in both populations, and in two additional domains, access and coordination of care, in the high-risk population. The high-risk population presents a major focus of this study, and specifically with regard to these domains, since such patients are more likely than others to seek access, and have more aspects of care that need to be coordinated.
This study addressed potential confounding effects of preexisting practice-level differences by including both hospital employment and practice size as covariates in the analyses. Small practice size predicted better ratings in the access domain-but this works against our hypothesis, since MiPCT early-adopter practices were more frequently large practices.
LIMITATIONS
The analysis used weighting and covariate controls to minimize non-response bias (see online Appendix for additional information). The study would be stronger if we were able to employ a longitudinal design. This would enable us to better disentangle the relative contributions of having more time for transformation versus the extra resources provided by MiPCT.
It would also enable difference-in-difference modeling to compare how both MiPCT and comparison patient experience may have changed over time, while accounting for unmeasured differences between the practices that may have been present at baseline and were unrelated to PCMH adoption. We also recognize that our study may have found statistical significance where the clinical significance is relatively small. Small effect sizes are quite common when working with aggregated patient experience data. Despite this limitation, we noted consistent and statistically significant results between MiPCT and comparison practices across patient experience domains, with an apparent Bdose^effect (highest experience scores for MiPCT patients, followed by non-participating PCMH, and then by non-PCMH patients). No other variable had such a consistent relationship with the outcome domains.
The generalizability of our results could be limited by factors specific to Michigan. A recent study reports considerable variation in implementation parameters among multipayer initiatives, including convener identity, payment methodology, performance measures, and practice participation criteria. 20 However, we believe that Michigan's size and diversity likely make it comparable to many other areas of the country.
CONCLUSION
This study shows that PCMH implementation is sufficient to confer benefits in some domains of patient experience, particularly in the high-risk population. Moreover, a more mature and advanced multi-payer model has an even stronger association with better patient experiences for both high-risk and general populations. At a time when multi-payer PCMH initiatives are taking hold throughout the country, and seem poised to provide platforms to advance larger delivery systems and payment reforms, it is critically important to evaluate the impact of such initiatives on outcomes, including patient experience.
